What top holdings OnKure Therapeutics OKUR Smart Money Active 20260427 Strait of Hormuz Disruption Asian Supply Shock Spillover Risks for the US Economy SYRE Spyre Therapeutics reports narrower Q4 2025 pershare loss than consensus forecasts with shares edging higher in todays trading